Distinguished Scientist, Pharmacokinetics

MSD•Boston, MA

1d•$210,400 - $331,100•Hybrid

About The Position

The department of Pharmacokinetics, Dynamics, Metabolism and Bioanalytics (PDMB) is seeking a Distinguished Scientist to serve as Drug Metabolism and Pharmacokinetics (DMPK) submission expert. This leader will have broad responsibilities in support of our robust development pipeline to ensure consistent quality filings from FIH to marketing applications and through life-cycle management. The Distinguished Scientist will contribute to the execution of PDMB portfolio support strategy and DMPK priorities across therapeutic areas and modalities. The successful candidate will ensure that submission packages as they pertain to nonclinical Pharmacokinetics (PK) are robust and aligned with program objectives. They will bring forward drug disposition properties in the context of benefit/risk and drug interaction potential in target populations within the parameters of regulatory guidelines. The Distinguished Scientist will be positioned to influence portfolio decisions, contribute to regulatory filings, labeling discussions and approvals. As a member of the DMPK Leadership team, the Distinguished Scientist will contribute to global scientific and portfolio strategy and talent development. They are expected to demonstrate exemplary ways of working, strong ethics, good negotiation skills and an enterprise mindset.

Requirements

Minimum experience of 15 years in DMPK with extensive experience as team representative in drug discovery and development programs.
Strong scientific acumen, as well as understanding of the drug development process and relevant regulatory guidelines. with a track-record of successful support of clinical candidates and first-in-human execution.
Previous experience collaborating with and mentoring program team representatives on an array of nonclinical and clinical issues.
Strong leadership skills and ability to work, collaborate with and influence scientists across a wide range of scientific disciplines to effectively influence strategic direction.
Efficient organizational skills and excellent verbal and written communications with ability to develop and deliver clear and concise documents and presentations.
Experience in authoring and critically reviewing nonclinical PK packages and clinical sections of relevant regulatory documents (IBs, INDs, CTAs, NDAs, BLAs, MAAs, PIP/PSPs, Scientific Advice, weight of evidence risk assessments, regulatory responses, product labels, etc.).
Demonstrated experience navigating issues and regulatory requirements for advancing drug development candidates across modalities from preclinical through Phase 4 development, regulatory approvals and/or post-approval commitments.
Drug Development
Drug Metabolism
Pharmacokinetics
Portfolio Strategies
Regulatory Filings
Regulatory Strategies
Regulatory Submissions
Scientific Leadership
Small Molecules

Nice To Haves

Extensive experience in early development and product development teams
Experience in Scientific Advisory Committee Meetings with the FDA and/or other regulatory agencies.
Deep understanding of filing and labeling requirements across major world markets
Current Employees apply HERE
Current Contingent Workers apply HERE
US and Puerto Rico Residents Only:
Our company is committed to inclusion, ensuring that candidates can engage in a hiring process that exhibits their true capabilities. Please click here if you need an accommodation during the application or hiring process.
As an Equal Employment Opportunity Employer, we provide equal opportunities to all employees and applicants for employment and prohibit discrimination on the basis of race, color, age, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability status, or other applicable legally protected characteristics. As a federal contractor, we comply with all affirmative action requirements for protected veterans and individuals with disabilities. For more information about personal rights under the U.S. Equal Opportunity Employment laws, visit:
EEOC Know Your Rights
EEOC GINA Supplement We are proud to be a company that embraces the value of bringing together, talented, and committed people with diverse experiences, perspectives, skills and backgrounds. The fastest way to breakthrough innovation is when people with diverse ideas, broad experiences, backgrounds, and skills come together in an inclusive environment. We encourage our colleagues to respectfully challenge one another’s thinking and approach problems collectively.
Learn more about your rights, including under California, Colorado and other US State Acts
San Francisco Residents Only: We will consider qualified applicants with arrest and conviction records for employment in compliance with the San Francisco Fair Chance Ordinance
Los Angeles Residents Only: We will consider for employment all qualified applicants, including those with criminal histories, in a manner consistent with the requirements of applicable state and local laws, including the City of Los Angeles’ Fair Chance Initiative for Hiring Ordinance
Search Firm Representatives Please Read Carefully
Merck & Co., Inc., Rahway, NJ, USA, also known as Merck Sharp & Dohme LLC, Rahway, NJ, USA, does not accept unsolicited assistance from search firms for employment opportunities. All CVs / resumes submitted by search firms to any employee at our company without a valid written search agreement in place for this position will be deemed the sole property of our company. No fee will be paid in the event a candidate is hired by our company as a result of an agency referral where no pre-existing agreement is in place. Where agency agreements are in place, introductions are position specific. Please, no phone calls or emails.

Responsibilities

Monitor the progression of programs in late-stage development and post-marketing to ensure nonclinical packages in support of original marketing applications (OMA) and supplemental applications (sNDA) are robust, prepared timely, according to filing strategy and aligned with clinical safety and efficacy positions
Represent PDMB in Label Approval Strategy Teams and in ad-hoc discussions/ teams where DMPK expertise is required, such as Clinical Safety/Risk Management, nonclinical safety mechanistic investigations as they pertain to regulatory filings, ICH guidance or label updates.
Reviewing investigator brochures, clinical trial applications, IND, NDAs, regulatory responses and other legal/scientific documents to support global clinical trials and registration.
Provide scientific and strategic oversight for development candidates across therapeutic areas through close collaboration with PDMB program representatives, subject-matter experts and management as well as key partners in other functional areas, including but not limited to Nonclinical Safety, Translational Medicine, Quantitative Pharmacology, Regulatory Affairs, Formulation and others to ensure alignment on regulatory strategy and input for mechanistic investigations.
Actively contribute to discussions regarding Clinical Pharmacology strategy, including starting dose, dose escalation, timing, design and interpretation of Ph1 studies, such as drug interactions, especial populations and human ADME amongst other studies, leveraging nonclinical data generated by PDMB.
Ensuring DMPK data and documentation practices maintain quality in pace with changes in regulatory expectations across countries/regions.
Leading internal and cross-departmental initiatives to improve policies, procedures, and/or strategic direction in line with company portfolio strategy and regulatory expectations.
Responsible for overseeing and/or conducting critical due diligence reviews for in-licensing assets across Therapeutic Areas and serve as integration lead. Serve as program representative for high-priority development programs.
Contribute to the development of future leaders to build organizational experience in drug development, regulatory processes, risk assessments and regulatory guidelines